CTOs on the Move

DEM Biopharma, Inc.

www.dembiopharma.com

 
DEM Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting ‘Dont eat me (DEM) and ‘Eat me (EM) signals on cancer cells and macrophages. Founded by Longwood Fund and is supported by a syndicate of biotech investors and headquartered in Boston, MA.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Harrigan and Hanten, P.C.

Harrigan and Hanten, P.C. is a Washington, DC-based company in the Business Services sector.

IRM Corporation

IRM Corporation is a Dallas, TX-based company in the Business Services sector.

Solar

ORTEMS Americas

ORTEMS Americas is a Warrenville, IL-based company in the Business Services sector.

MarketTools

MarketTools is a San Francisco, CA-based company in the Business Services sector.